Zhou, J., Toh, S. H., Chan, Z., Quah, J. Y., Chooi, J., Tan, T. Z., . . . Chng, W. (2018). A loss-of-function genetic screening reveals synergistic targeting of AKT/mTOR and WTN/β-catenin pathways for treatment of AML with high PRL-3 phosphatase. J Hematol Oncol.

Zhou, Jianbiao, Sabrina Hui-Min Toh, Zit-Liang Chan, Jessie Yiying Quah, Jing-Yuan Chooi, Tuan Zea Tan, Phyllis S. Y. Chong, Qi Zeng, and Wee-Joo Chng. "A Loss-of-function Genetic Screening Reveals Synergistic Targeting of AKT/mTOR and WTN/β-catenin Pathways for Treatment of AML With High PRL-3 Phosphatase." J Hematol Oncol 2018.

Zhou, Jianbiao, et al. "A Loss-of-function Genetic Screening Reveals Synergistic Targeting of AKT/mTOR and WTN/β-catenin Pathways for Treatment of AML With High PRL-3 Phosphatase." J Hematol Oncol 2018.